DekaBank Deutsche Girozentrale’s Kura Oncology KURA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$732K	Hold	95,000	–	–	﹤0.01%	832
2026 Q1	$747K	Hold	95,000	–	–	﹤0.01%	833
2025 Q4	$2.19M	Hold	95,000	–	–	﹤0.01%	757
2025 Q3	$840K	Hold	95,000	–	–	﹤0.01%	906
2025 Q2	$557K	Hold	95,000	–	–	﹤0.01%	965
2025 Q1	$655K	Hold	95,000	–	–	﹤0.01%	915
2024 Q4	$808K	Hold	95,000	–	–	﹤0.01%	916
2024 Q3	$1.83M	Hold	95,000	–	–	﹤0.01%	774
2024 Q2	$1.93M	Hold	95,000	–	–	﹤0.01%	771
2024 Q1	$1.99M	Hold	95,000	–	–	﹤0.01%	758
2023 Q4	$1.34M	Buy	95,000 +65,000	+217%	+$639K	﹤0.01%	854
2023 Q3	$262K	Buy	+30,000	New	+$305K	﹤0.01%	1148
2022 Q4	–	Sell	-24,900	Closed	-$327K	–	1375
2022 Q3	$327K	Hold	24,900	–	–	﹤0.01%	1123
2022 Q2	$448K	Hold	24,900	–	–	﹤0.01%	1035
2022 Q1	$401K	Buy	24,900 +2,300	+10%	+$33.2K	﹤0.01%	1099
2021 Q4	$328K	Buy	22,600 +600	+3%	+$9.72K	﹤0.01%	1180
2021 Q3	$410K	Hold	22,000	–	–	﹤0.01%	1094
2021 Q2	$470K	Sell	22,000 -45,000	-67%	-$1.12M	﹤0.01%	1080
2021 Q1	$1.78M	Hold	67,000	–	–	0.01%	733
2020 Q4	$2.26M	Sell	67,000 -69,400	-51%	-$2.44M	0.01%	644
2020 Q3	$4.13M	Buy	+136,400	New	+$3.01M	0.02%	447
2019 Q3	–	Sell	-19,600	Closed	-$388K	–	1067
2019 Q2	$388K	Buy	19,600 +7,600	+63%	+$126K	﹤0.01%	952
2019 Q1	$235K	Buy	12,000 +2,200	+22%	+$33.9K	﹤0.01%	1019
2018 Q4	$127K	Sell	9,800 -2,200	-18%	-$29.1K	﹤0.01%	1033
2018 Q3	$235K	Sell	12,000 -300	-2%	-$5.75K	﹤0.01%	1041
2018 Q2	$213K	Hold	12,300	–	–	﹤0.01%	1037
2018 Q1	$226K	Buy	+12,300	New	+$239K	﹤0.01%	978

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

DekaBank Deutsche Girozentrale's KURA Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Kura Oncology (KURA) position steady in Q2 2026 at 95,000 shares worth $732K. The position accounts for ﹤0.01% of the portfolio, ranked #832.

DekaBank Deutsche Girozentrale first reported a position in KURA in Q1 2018 and has held it in 27 quarters since. The position peaked at $4.13M in Q3 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

DekaBank Deutsche Girozentrale held 95,000 shares of Kura Oncology worth $732K as of Q2 2026.
DekaBank Deutsche Girozentrale left its Kura Oncology share count unchanged in Q2 2026.
Kura Oncology made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #832 holding.
DekaBank Deutsche Girozentrale first reported a position in Kura Oncology in Q1 2018 and has held it in 27 quarters since.
DekaBank Deutsche Girozentrale's Kura Oncology position peaked at $4.13M in Q3 2020.
221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.